The increasing interest in effective weight management has spurred considerable investigation into cutting-edge treatments. Lately , Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and peptide receptor agonist , has demonstrated promising results in patient trials, indicating potential for substantial weight loss . Th